Co-Diagnostics Reports Strong Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Co-Diagnostics (CODX) Tops Q2 EPS by 11c
August 12, 2021 4:03 PM EDTCo-Diagnostics (NASDAQ: CODX) reported Q2 EPS of $0.33, $0.11 better than the analyst estimate of $0.22. Revenue for the quarter came in at $27.4 million versus the consensus estimate of $20.77 million.
GUIDANCE:
Co-Diagnostics sees Q3 2021 EPS of $0.19-$0.22, versus the consensus of $0.18. Co-Diagnostics sees... More
